Lupin Rivaroxaban Tablets approved by USFDA Ruchika Sharma16 May 2025 12:23 PM ISTMumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated...
USFDA clears Alembic Pharma cardio drug Rivaroxaban, launch expected in next year Ruchika Sharma15 May 2025 3:26 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA)...
Aurobindo Pharma gets USFDA final, tentative nod for different strengths of deep vein thrombosis drug Rivaroxaban Ruchika Sharma14 April 2025 11:30 AM ISTAurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and...
Lupin unveils heart drug Rivaroxaban in US Ruchika Sharma8 March 2025 11:41 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the final approval of...
Alembic Pharma receives USFDA approval for schizophrenia drug Paliperidone Extended Release Ruchika Sharma27 Sept 2024 4:40 PM ISTMumbai: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA)...
Lupin bags tentative USFDA approval for Rivaroxaban Tablets Ruchika Sharma24 Jan 2024 11:19 AM ISTThis product will be manufactured at Lupin's Pithampur facility in India.
Indoco Remedies Canagliflozin Tablets for type 2 diabetes adults get USFDA tentative okay Ruchika Sharma6 Dec 2023 5:01 PM ISTCanagliflozin improves glycemic control in adults with type 2 diabetes mellitus.
Lupin type 2 diabetes drug Canagliflozin bags USFDA tentative approval Ruchika Sharma24 Nov 2023 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
Sanofi completes closing for potential vaccine against extraintestinal pathogenic E.coli Ruchika Sharma12 Nov 2023 5:00 PM ISTParis: Sanofi has announced the completion of closing for its collaborative agreement with Janssen Pharmaceuticals, Inc., a Johnson & Johnson...
Lupin gets tentative USFDA nod for Canagliflozin, Metformin Hydrochloride ER tablets Ruchika Sharma8 Nov 2023 10:52 AM ISTCanagliflozin and Metformin Hydrochloride Extended-Release Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in...
GSK enters agreement to obtain exclusive license for hepatitis B therapy to expand bepirovirsen development Ruchika Sharma1 Nov 2023 11:30 AM ISTGSK will be responsible for upfront and potential milestone-based payments to both Janssen and Arrowhead totalling approximately USD 1 billion.
HIV-1 injectable treatment: GSK's ViiV Healthcare gets Chinese nod for Vocabria used in combination with Rekambys Ruchika Sharma26 Oct 2023 4:21 PM ISTLondon: GSK plc has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as...
